EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients

Ji Yun Lee, Ju-Hyun Lee, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim und 4 weitere

Cancer Research and Treatment · 15.04.2025 · 57 (2) · 612-620

DOI: 10.4143/crt.2024.738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, erschienen am 15.04.2025. Verfasst von Ji Yun Lee und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Anticoagulants, Venous Thromboembolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Seoul National University Bundang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Thrombosis and bleeding significantly affect morbidity and mortality in myeloproliferative neoplasms (MPNs). The efficacy and safety of direct oral anticoagulants (DOACs) in MPN patients remain uncertain.Materials and Methods We conducted a large, retrospective, nationwide cohort study using the Korean Health Insurance Review and Assessment Service database from 2010 to 2021.

Results

Out of the 368 MPN patients included in the final analysis, 62.8% were treated with DOACs for atrial fibrillation (AF), and 37.2% for venous thromboembolism (VTE). The AF group was statistically older with higher CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65-74 years, sex category [female]) scores compared to the VTE group. Antiplatelet agents were used in 51.1% of cases, and cytoreductive drugs in 79.3%, with hydroxyurea being the most common (64.9%). The median follow-up was 22.3 months, with 1-year cumulative incidence rates of thrombosis and bleeding at 11.1% and 3.7%, respectively. Multivariate analysis identified CHA2DS2-VASc scores ≥ 3 (hazard ratio [HR], 3.48), concomitant antiplatelet use (HR, 2.57), and cytoreduction (HR, 2.20) as significant thrombosis risk factors but found no significant predictors for major bleeding.

Conclusion

Despite the limitations of retrospective data, DOAC treatment in MPN patients seems effective and has an acceptable bleeding risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloproliferative DisordersAnticoagulantsVenous ThromboembolismHumansMaleFemaleAgedRetrospective StudiesMiddle AgedAdministration, OralHemorrhageAtrial FibrillationAged, 80 and overRepublic of KoreaThrombosisAdultRisk Factors

Stichwörter der Autor:innen

Direct oral anticoagulantsHemorrhageMyeloproliferative neoplasmsThrombosis

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Förderung

  • Seoul National University Bundang Hospital

Zitieren

APA

Lee, J. Y., Lee, J. H., Park, W., Seo, J., Kang, M., Jung, E. H., Kim, S. A., Suh, K. J., Kim, J. W., Kim, S. H., Lee, J. O., Kim, J. W., Kim, Y. J., Lee, K. W., Kim, J. H., & Bang, S. M. (2025). The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients. Cancer Research and Treatment, 57(2), 612-620. https://doi.org/10.4143/crt.2024.738

Vancouver

Lee JY, Lee JH, Park W, Seo J, Kang M, Jung EH, et al. The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients. Cancer Research and Treatment. 2025;57(2):612-620. doi:10.4143/crt.2024.738

BibTeX
@article{Lee2025,
  author = {Lee, Ji Yun and Lee, Ju-Hyun and Park, Woochan and Seo, Jeongmin and Kang, Minsu and Jung, Eun Hee and Kim, Sang-A and Suh, Koung Jin and Kim, Ji-Won and Kim, Se Hyun and Lee, Jeong-Ok and Kim, Jin Won and Kim, Yu Jung and Lee, Keun-Wook and Kim, Jee Hyun and Bang, Soo-Mee},
  title = {The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients},
  journal = {Cancer Research and Treatment},
  year = {2025},
  volume = {57},
  number = {2},
  pages = {612--620},
  doi = {10.4143/crt.2024.738}
}
Kostenlos starten →